Neem's Hill AB (STO:NEEMS.B)
Sweden · Delayed Price · Currency is SEK 3.100
+0.050 (1.64%)
At close: Aug 12, 2026
Neem's Hill AB Company Description
Neem's Hill AB, a medical technology company, engages in the development of patented treatment alternatives for humans and animals with cancer in Sweden and internationally.
It offers IQwave, an electroporation that generates tumor-specific electrical stimulation for the treatment of solid superficial tumors of various sizes and locations.
Neem's Hill AB was formerly known as Scandinavian ChemoTech AB (publ) and changed its name to Neem's Hill AB in July 2026.
The company was incorporated in 2013 and is headquartered in Lund, Sweden.
Neem's Hill AB
| Country | Sweden |
| Founded | 2013 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 1 |
| CEO | Stefan Frick |
Contact Details
Address: Medicon Village Lund, 223 63 Sweden | |
| Phone | 46 1 02 18 93 00 |
| Website | chemotech.se |
Stock Details
| Ticker Symbol | NEEMS.B |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Stefan Frick | Chief Executive Officer |
| Ann Ohlsson | Chief Financial Officer |